Clostridium Difficile Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Phase 3 CLOVER Trial for Pfizer ’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints
Pre-specified secondary endpoint showed 0-11 vaccine to placebo case split for medically attended C. difficile infection (CDI), corresponding to 100% vaccine efficacy Median CDI duration was 1 versus 4 days and mean duration was 3 versus 16... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 1, 2022 Category: Pharmaceuticals Source Type: clinical trials

Prevention of C.Difficile Infections With Oral Vancomycine in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
Conditions: Clostridium Difficile Infections; Stem Cell Transplant Complications Interventions: Drug: Vancomycin; Drug: Placebo Sponsors: Assistance Publique - Hôpitaux de Paris; GIRCI Ile de France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 25, 2022 Category: Research Source Type: clinical trials